alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1
CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Annual Report of Global Med Technologies, Inc. (the
Company) on Form 10-K for the period ended December 31, 2004 as
filed with the Securities and Exchange Commission on the date hereof (the
Report), the undersigned, in the capacities and on the dates
indicated below, hereby certifies, pursuant to 18 U.S.C. section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the
best of my knowledge:

|(1) |  | The
Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act  of 1934; and
|--- |  | ----------------------------------------------------------------------------------------------------------------------

|(2) |  | The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------

Dated: March 1,
2005

| | /s/ Michael I. Ruxin, M.D.
Name:  Michael I. Ruxin, M.D.
Chief Executive Officer
| | --------------------------------------------------------------------------------

A
signed original of this written statement required by Section 906, or other
documentation authentications, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this
written statement required by Section 906, has been provided to Global Med
Technologies, Inc. and will be retained by Global Med Technologies, Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.

---
exv10w9







EXHIBIT 10.09




JOINT FILING AGREEMENT




Each of the undersigned hereby agrees and consents that the Schedule 13D/A filed herewith (the
“Schedule 13D/A”) by Steven M. Lutz is filed on behalf of each of them pursuant to the
authorization of the undersigned to make such filing and that such Schedule 13D/A is filed jointly
on behalf of each of them, pursuant to Sections 13(d) and 13(g) of the Securities Exchange Act of
1934, as amended, and the rules promulgated thereunder, including Rule 13d-1(k)(1). Each of the
undersigned hereby agrees that such Schedule 13D/A is, and any further amendments to the Schedule
13D/A will be, filed on behalf of each of the undersigned. Each of the persons is not responsible
for the completeness or accuracy of the information concerning the other persons making this filing
unless such person knows or has reason to believe that such information is inaccurate. This
agreement may be signed in counterparts. This agreement is effective
as of May 18, 2009.



	 	 	 	 	 
	 	LUTZ FAMILY LIMITED PARTNERSHIP
 	 
	Dated: May 18, 2009 	

/s/ Steven M. Lutz
 	 
	 	Name:  	Steven M. Lutz 	 
	 	Title:  	General Partner 	 
	 
	 	 	 
	 	                         /s/ Steven M. Lutz
 	 
	 	Steven M. Lutz
NOTE: This order is nonprecedential.

United States Court of Appeals 

for the Federal Circuit ______________________ 

NEAPOLEON JWAN FREEMAN, SR.,

Plaintiff-Appellant,

v.

UNITED STATES,

Defendant-Appellee.

______________________ 

2014-5023

______________________ 

Appeal from the United States Court of Federal 

Claims in No. 1:13-cv-00327-EJD, Judge Edward J. 

Damich.

______________________ 

ON MOTION

______________________ 

PER CURIAM. 

O R D E R

The court construes Neapoleon Jwan Freeman, Sr.’s 

April 21, 2014 letter as a motion for various relief, including the appointment of counsel. 

Upon consideration thereof, 

 IT IS ORDERED THAT: 

Case: 14-5023 Document: 14 Page: 1 Filed: 05/30/2014
2 FREEMAN v. US

The motion is denied.

 FOR THE COURT

 /s/ Daniel E. O’Toole 

 Daniel E. O’Toole 

 Clerk of Court

s24

Case: 14-5023 Document: 14 Page: 2 Filed: 05/30/2014
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                         834,548
<SECURITIES>                                         0
<RECEIVABLES>                                1,757,061
<ALLOWANCES>                                         0
<INVENTORY>                                  1,042,509
<CURRENT-ASSETS>                             3,975,686
<PP&E>                                       5,796,233
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              12,564,295
<CURRENT-LIABILITIES>                        1,702,471
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        157
<COMMON>                                        82,024
<OTHER-SE>                                   2,916,862
<TOTAL-LIABILITY-AND-EQUITY>                12,564,295
<SALES>                                      5,710,352
<TOTAL-REVENUES>                             5,710,352
<CGS>                                        3,404,708
<TOTAL-COSTS>                                3,404,708
<OTHER-EXPENSES>                             3,126,319
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             411,368
<INCOME-PRETAX>                            (1,188,955)
<INCOME-TAX>                                     4,725
<INCOME-CONTINUING>                        (1,193,680)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,193,680)
<EPS-PRIMARY>                                    (.15)
<EPS-DILUTED>                                    (.15)
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1994             DEC-31-1994
<PERIOD-END>                               SEP-30-1995             SEP-30-1995
<CASH>                                           29369                   29369
<SECURITIES>                                     25566                   25566
<RECEIVABLES>                                    44281                   44281
<ALLOWANCES>                                       899                     899
<INVENTORY>                                       2632                    2632
<CURRENT-ASSETS>                                101449                  101449
<PP&E>                                           56466                   56466
<DEPRECIATION>                                   35659                   35659
<TOTAL-ASSETS>                                  124987                  124987
<CURRENT-LIABILITIES>                            40392                   40392
<BONDS>                                              0                       0
<COMMON>                                          8269                    8269
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<OTHER-SE>                                       72728                   72728
<TOTAL-LIABILITY-AND-EQUITY>                    124987                  124987
<SALES>                                          33945                   89770
<TOTAL-REVENUES>                                 33945                   89770
<CGS>                                            24235                   64249
<TOTAL-COSTS>                                    26989                   72075
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                   120                     420
<INTEREST-EXPENSE>                                  26                      79
<INCOME-PRETAX>                                   7489                   19176
<INCOME-TAX>                                      2675                    6866
<INCOME-CONTINUING>                               4841                   12381
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                      4841                   12381
<EPS-PRIMARY>                                      .19                     .48
<EPS-DILUTED>                                      .19                     .48
        

</TABLE>
Exhibit 15.1  KPMG LLP
Telephone
(416) 228-7000Bay Adelaide Centre
Fax
(416) 228-7123333 Bay Street,   Suite 4600
Internet
www.kpmg.caToronto, ONM5H 2S5  Consent of Independent Registered Public Accounting Firm  The Board of Directors  Celestica Inc.  We consent to the incorporation by reference in the registration statements on Form S-8 (Nos. 333-113591, 333-88210, 333-71126, 333-66726, 333-63112 and 333-9500) and Form F-3ASR (No. 333-199616)of Celestica Inc. of our report dated March 9, 2017, on the consolidated financial statements of Celestica Inc., which comprise the consolidated balance sheets as of December 31, 2016 and December 31, 2015 and the related consolidated statements of operations, comprehensive income, changes in equity and cash flows for each of the years in the three-year period ended December 31, 2016, and our audit report dated March 9, 2017 on the effectiveness of internal control over financial reporting, which reports appear in the annual report on Form 20-F of Celestica Inc. for the fiscal year ended December 31, 2016.    Chartered Professional Accountants, Licensed Public Accountants March 13, 2017 Toronto, Canada  KPMG LLP is a Canadian limited liability partnership and a member firm of the KPMG network of independent member firms affiliated with KPMG Intemational Cooperative (KPMG International), a Swiss entity.  KPMG Canada provides services to KPMG LLP.
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

241 CA 13-01151 PRESENT: SCUDDER, P.J., SMITH, CARNI, LINDLEY, AND SCONIERS, JJ.

CATHLEEN CAMACHO, PLAINTIFF-RESPONDENT,

V MEMORANDUM AND ORDER

CHRISTOPHER CAMACHO, DEFENDANT-APPELLANT.

VENZON LAW FIRM PC, BUFFALO (CATHARINE M. VENZON OF COUNSEL), FOR DEFENDANT-APPELLANT.

TIMOTHY J. PAWARSKI, ELMA, FOR PLAINTIFF-RESPONDENT.

GAYLE T. MURPHY, ATTORNEY FOR THE CHILD, HAMBURG.

Appeal from an order of the Supreme Court, Erie County (Henry J. Nowak, Jr., J.), entered April 18, 2013. The order, among other things, denied that part of defendant’s motion seeking access to the subject child “until the child’s counselor agrees that it would be appropriate.”
It is hereby ORDERED that the order so appealed from is unanimously modified on the law by vacating the provision conditioning defendant’s access to the child upon the agreement of the child’s counselor, and as modified the order is affirmed without costs, and the matter is remitted to Supreme Court, Erie County, for further proceedings in accordance with the following Memorandum: Defendant appeals from an order that, inter alia, denied that part of his motion seeking access with the parties’ child “until the child’s counselor agrees that it would be appropriate.” We agree with defendant that Supreme Court thereby improperly delegated to the child’s counselor the court’s authority to determine issues involving the best interests of the child ( see Matter of Hameed v Alatawaneh , 19 AD3d 1135, 1136; Matter of Henrietta D. v Jack K ., 272 AD2d 995, 995). We therefore modify the order accordingly, and we remit the matter to Supreme Court for a determination of that part of defendant’s motion seeking access with the child.

Entered: March 28, 2014 Frances E. Cafarell Clerk of the Court
Summary of Board of Directors Compensation



 Exhibit 10.8 
 Invitel Holdings A/S 
 Compensation Structure for its Board of Directors 
 2008 to 2009 Term 
 Board Service 
 2,000 shares of stock vesting after one-year term 
 $10,000 retainer payable
in quarterly installments 
 $1,000 per in person meeting 
 $500
per telephone meeting 
 Audit Committee Service – Chairman 
 $10,000 retainer payable in quarterly installments 
 Audit Committee Service – Chairman and Non-Chairmen 
 $1,000 per in person meeting 
 $500 per telephone meeting
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 00-6052

GARY LEE HARRIS, Plaintiff - Appellant,
versus RONALD J. ANGELONE, Director of the Virginia Department of Corrections; A. D. ROBERTSON, Warden of Nottoway Correctional Center; T. C. ESTEP, Assistant Warden of Programs; LOUIS B. CEI, Chairman of the Virginia Department of Corrections, Central Classification Board;PATRICK GURNEY, Former Manager of the Classification and Records Section of the Departmentof Corrections; JOHN DOE, Manager of the Classification Board; GENE JOHNSON, AssistantDirector of the Virginia Department of Corrections; JOHN R. ALDERMAN, Chairman of the Virginia Parole Board, Defendants - Appellees.
Appeal from the United States District Court for the Eastern District of Virginia, at Alexandria. Albert V. Bryan, Jr., Senior District Judge. (CA-99-711-AM) Submitted: April 13, 2000 Decided: April 21, 2000 Before WIDENER and WILKINS, Circuit Judges, and HAMILTON, Senior Circuit Judge. Dismissed by unpublished per curiam opinion.2 Gary Lee Harris, Appellant Pro Se. Pamela Anne Sargent, Assistant Attorney General, Richmond, Virginia, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM: Gary Lee Harris, a Virginia inmate, appeals the district court’s order denying relief on his 42 U.S.C.A. § 1983 (West Supp. 1999) complaint under 28 U.S.C.A. § 1915A (West Supp. 1999). We have reviewed the record and the district court’s opinion and find that this appeal is frivolous. Accordingly, we dismiss the appeal on the reasoning of the district court. See Harris v. Angelone , No. CA-99-711-AM (E.D. Va. Dec. 17, 1999). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0001031002
<NAME>                        MERRILL LYNCH PREFERRED FUNDING II, L.P.
       
<S>                             <C>
<PERIOD-TYPE>                   OTHER
<FISCAL-YEAR-END>                        DEC-25-1998
<PERIOD-START>                           DEC-27-1997
<PERIOD-END>                             DEC-25-1998
<CASH>                                             0
<SECURITIES>                             363,989,866
<RECEIVABLES>                              7,204,368
<ALLOWANCES>                                       0
<INVENTORY>                                        0
<CURRENT-ASSETS>                         371,194,234
<PP&E>                                             0
<DEPRECIATION>                                     0
<TOTAL-ASSETS>                           371,194,234
<CURRENT-LIABILITIES>                      7,204,368
<BONDS>                                            0
<PREFERRED-MANDATORY>                              0
<PREFERRED>                              309,278,400
<COMMON>                                  54,711,466
<OTHER-SE>                                         0
<TOTAL-LIABILITY-AND-EQUITY>             371,194,234
<SALES>                                            0
<TOTAL-REVENUES>                          29,016,924
<CGS>                                              0
<TOTAL-COSTS>                                      0
<OTHER-EXPENSES>                                   0
<LOSS-PROVISION>                                   0
<INTEREST-EXPENSE>                                 0
<INCOME-PRETAX>                           29,016,924
<INCOME-TAX>                                       0
<INCOME-CONTINUING>                       29,016,924
<DISCONTINUED>                                     0
<EXTRAORDINARY>                                    0
<CHANGES>                                          0
<NET-INCOME>                              29,016,924
<EPS-PRIMARY>                                      0
<EPS-DILUTED>                                      0
        


</TABLE>
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

    In connection with the Annual Report of Bluefly, Inc. (the "Company") on
Form 10-K for the year ending December 31, 2007, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Melissa Payner-
Gregor, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

    1.  The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

    2.  The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

/s/ Melissa Payner-Gregor
-------------------------

Melissa Payner-Gregor
---------------------
Chief Executive Officer
-----------------------
March 27, 2008
--------------
II

106TH CONGRESS

2D SESSION S. 2206

To suspend temporarily the duty on Cyclohexadecadlenel,9 (CHDD).

IN THE SENATE OF THE UNITED STATES

MARCH 7, 2000

Mr. THURMOND introduced the following bill; which was read twice and

referred to the Committee on Finance

A BILL

To suspend temporarily the duty on Cyclohexadecadlenel,9

(CHDD).

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. CYCLOHEXADECADLENEL,9 (CHDD).

4 (a) IN GENERAL.—Subchapter II of chapter 99 of

5 the Harmonized Tariff Schedule of the United States is

6 amended by inserting in numerical sequence the following

7 new heading:

‘‘ 9902.28.12 Cyclohexadecadlenel,9 (CHDD)

(provided for in

subheading

2902.90.80) ....... Free Free No change On or before

12/31/2003 ’’.
2

•S 2206 IS

1 (b) EFFECTIVE DATE.—The amendment made by

2 subsection (a) applies with respect to goods entered, or

3 withdrawn from warehouse for consumption, on or after

4 the 15th day after the date of the enactment of this Act.

Æ
- HHSToCongressDenied_P0059_07292008_V02.pdf
Harry Reid.pdf
Mitch McConnell.pdf
Nancy Pelosi.pdf
John Boehner.pdf

- Richard Cheney.pdf
[Federal Register Volume 75, Number 92 (Thursday, May 13, 2010)]
[Notices]
[Page 26968]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-11307]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Eye Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Eye Institute Special Emphasis 
Panel; NEI Loan Repayment Grants.
    Date: May 18-19, 2010.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Eye Institute, 5635 Fishers Lane, Bethesda, MD 
(Virtual Meeting).
    Contact Person: Daniel R. Kenshalo, PhD, Scientific Review 
Officer, National Eye Institute, National Institutes of Health, 5635 
Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD 20892, 301-451-
2020, <a href="/cdn-cgi/l/email-protection#ec8789829f848d808388ac828985c2828584c28b839a"><span class="__cf_email__" data-cfemail="a8c3cdc6dbc0c9c4c7cce8c6cdc186c6c1c086cfc7de">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Eye Institute Special Emphasis 
Panel; SBIR Grant Application.
    Date: May 20, 2010.
    Time: 12 p.m. to 2 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Eye Institute, 5635 Fishers Lane, Suite 1300, 
Rockville, MD 20892.
    Contact Person: Samuel Rawlings, PhD, Chief, Scientific Review 
Branch, Division Of Extramural Research, National Eye Institute, 
5635 Fishers Lane, Suite 1300 MSC 9300, Bethesda, MD 20892-9300, 
301-451-2020, <a href="/cdn-cgi/l/email-protection#98eaf9eff4f1f6ffebd8f6fdf1b6f6f1f0b6fff7ee"><span class="__cf_email__" data-cfemail="e39182948f8a8d8490a38d868acd8d8a8bcd848c95">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.867, 
Vision Research, National Institutes of Health, HHS)

    May 6, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-11307 Filed 5-12-10; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>